Dental bone graft substitutes market seen topping $5.7B by 2030

The dental bone graft substitutes market is projected to grow from $4.41 billion in 2025 to $5.76 billion by 2030, driven by more periodontal disease, more implant procedures and advances in biomaterials. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through 2030.

Why it matters: - Dental bone graft substitutes are a core input for oral surgeries that rebuild jawbone and support dental implants. - Rising demand matters because more patients need bone regeneration after tooth loss, periodontal disease, trauma or other dental conditions. - The market growth signals more use of restorative dental procedures and advanced biomaterials across clinics and surgical practices.

What happened: - The Business Research Company released a market report on dental bone graft substitutes on August 3, 2026. - The report projects the market will rise from $4.41 billion in 2025 to $4.65 billion in 2026. - The report forecasts the market will reach $5.76 billion by 2030. - The forecast implies a 5.6% CAGR from 2025 to 2026 and a 5.5% CAGR from 2026 to 2030.

The details: - Dental bone graft substitutes are biocompatible materials used to stimulate bone regeneration in oral and maxillofacial surgery. - The products help replace bone lost from tooth extractions, periodontal disease, trauma and other dental issues. - They provide a scaffold for new bone growth when natural bone volume or density is too low for implants or other restorative procedures. - The report links market growth to more periodontal disease, more dental implant procedures, biomaterial innovation, growth in oral surgery and greater patient awareness of restorative options. - The report also points to rising demand for bioengineered graft materials, minimally invasive grafting techniques, regenerative dental therapies and guided bone regeneration. - Investment in advanced biomaterials that promote faster bone healing is shaping the market outlook. - North America held the largest market share in 2025. - Asia-Pacific is expected to post the fastest growth during the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The report says 2026 editions include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based dashboards, market hotspots infographics, and updated graphics and tables. - The company offers a free sample report and the full market report. - Contact details listed in the release include Saumya Sahay and The Business Research Company, with phone numbers for the Americas, Asia and Europe and the email marketing@tbrc.info. - The release also lists The Business Research Company social links on LinkedIn, LinkedIn, Facebook and X.

Between the lines: - The forecast suggests dental care demand is being supported by both disease prevalence and elective restorative procedures such as implants. - The emphasis on guided bone regeneration, minimally invasive methods and bioengineered materials points to a market shift toward less invasive and more specialized products. - The regional split suggests mature adoption in North America and faster expansion opportunities in markets still building oral care infrastructure and awareness.

What's next: - The market is expected to keep expanding through 2030 as implant dentistry and regenerative treatments become more common. - Product development is likely to focus on biomaterials that improve healing speed and simplify grafting procedures. - Regional growth is likely to be strongest in Asia-Pacific as healthcare spending and oral care awareness rise.

The bottom line: - Dental bone graft substitutes are moving from a niche surgical material to a growing global market tied to implant dentistry, periodontal care and biomaterial innovation.